Seyed-Mahmood Seyed-Khorrami is a medical virologist with advanced academic training, holding a doctorate in medical virology from Tarbiat Modares University, a master’s degree in medical virology from Tehran University of Medical Sciences, and a bachelor’s degree in biology from Tabriz University. His professional experience spans diverse roles, including specialty expert at the Center for Disease Control and Prevention, laboratory technical officer and manager in research and development, consultant virologist in an HPV clinic, and active member of national COVID-19 diagnostic and research projects. He has also contributed as a teaching assistant in cell culture, virus propagation, and molecular techniques. His research interests focus on oncolytic viruses in cancer therapy, viral pathogenesis, emerging and re-emerging viral diseases, animal experiments, and nanotechnology-based vaccines and delivery systems. He possesses strong laboratory expertise in virus propagation, molecular diagnostics, cloning, flow cytometry, animal handling, and bioinformatics, alongside certifications in biosafety, GLP, and quality management. His publication record includes impactful contributions in international journals on cancer immunotherapy, COVID-19, viral epidemiology, and nanovaccine development, complemented by book authorship and conference presentations. He has served as a reviewer for multiple journals and has secured competitive grants for his research. Recognized for his scientific contributions, he demonstrates an outstanding blend of research skills, professional commitment, and leadership. In conclusion, his career reflects a dynamic integration of virology, translational research, and innovation with promising potential for impactful contributions to global health.
Salehi-Vaziri, M., Fazlalipour, M., Seyed Khorrami, S. M., Azadmanesh, K., … (2022). The ins and outs of SARS-CoV-2 variants of concern (VOCs). Archives of Virology, 167(2), 327-344. [Citations: 73]
Seyed-Khorrami, S. M., Soleimanjahi, H., Soudi, S., & Habibian, A. (2021). MSCs loaded with oncolytic reovirus: migration and in vivo virus delivery potential for evaluating anti-cancer effect in tumor-bearing C57BL/6 mice. Cancer Cell International, 21(1), 244. [Citations: 32]
Jafarpoor, A., Jazayeri, S. M., Bokharaei-Salim, F., Ataei-Pirkooh, A., … Seyed Khorrami, S. M. (2022). VDR gene polymorphisms are associated with the increased susceptibility to COVID-19 among Iranian population: A case-control study. International Journal of Immunogenetics, 49(4), 243-253. [Citations: 28]
Banijamali, R. S., Soleimanjahi, H., Soudi, S., Karimi, H., Abdoli, A., … Seyed-Khorrami, S. M. (2019). Kinetics of oncolytic reovirus T3D replication and growth pattern in mesenchymal stem cells. Cell Journal (Yakhteh), 22(3), 283. [Citations: 23]
Behboudi, E., Mokhtari-Azad, T., Yavarian, J., Ghavami, N., … Seyed Khorrami, S. M. (2019). Molecular detection of HHV1-5, AAV and HPV in semen specimens and their impact on male fertility. Human Fertility, 22(2), 133-138. [Citations: 20]
Charostad, J., Mokhtari-Azad, T., Yavarian, J., Ghavami, N., Seyed-Khorrami, S. M., … (2020). Detection of human herpes viruses 1-5 in miscarriage: A case-control study. International Journal of Reproductive BioMedicine, 18(7), 501. [Citations: 13]
Seyed Khorrami, S. M., Mokhtari-Azad, T., Yavarian, J., Fatemi Nasab, G. S., … (2015). The etiology of Rubella IgM positivity in patients with rubella-like illness in Iran from 2011 to 2013. Journal of Medical Virology, 87(11), 1846-1852. [Citations: 13]
Seyed-Khorrami, S. M., Soleimanjahi, H., Łos, M. J., Zandi, K., & Emameh, R. Z. (2023). Oncolytic viruses as emerging therapy against cancers including Oncovirus-induced cancers. European Journal of Pharmacology, 939, 175393. [Citations: 12]